BrainStorm Cell Therapeutics Announces Full Year 2024 Financial Results and Provides Corporate Update

Provided By PR Newswire

Last update: Mar 31, 2025

Conference call and webcast at 8:30 a.m. Eastern Time today

NEW YORK, March 31, 2025 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell therapeutics for neurodegenerative diseases, today announced financial results for the fiscal year ended December 31, 2024, and provided a corporate update.